nav-left cat-right
cat-right

Preclinical services news in brief – In this...

Belgian biopharma firm UCB has this week selected ZoBio to provide ligand screening services for some of its targets in the field of fragment-based drug discovery. ZoBio will undertake this task using its proprietary Target Immobilized Nuclear Magnetic Resonance (NMR) Screening (TINS) technology. According to ZoBio, TINS is capable of” rapidly generating high affinity, high specificity lead compounds with optimal...

BioServe Acquires Genomics Collaborative

BioServe Extends Genomics Services Platform with Premier Industrial Biobank for Biomarker Discovery and Validation Beltsville, MD, May 1st, 2007 – BioServe, a leading provider of genomics services, today announced that it has acquired Genomics Collaborative from SeraCare Life Sciences, Inc. Genomics Collaborative is a leader in facilitating biomarker discovery and validation through its Global Repository®, a...

Galapagos Announces Third Quarter 2005 Results

— Acquisition of BioFocus completed, integration progresses as planned — Galapagos year to date revenues 8% below last year’s revenues, but cash burn in line with forecast — Revenue guidance for 4Q ’05 of 7.7 million, full year cash burn of 7 million — Strong cash position of 25 million on Sept. 30, 2005 — Management further strengthened with appointment of David...

Fisher acquires Oakland company

Cellomics Inc., hailed as one of Pittsburgh’s most promising life science start-up companies, has been acquired by Fisher Scientific International Inc., a firm with century-old Pittsburgh roots. Hampton, N.H.-based Fisher, a maker of laboratory equipment, has been pushing aggressively into the life science arena with several acquisitions in recent years. Fisher Scientific said it will pay $49 million for Cellomics,...

Novasite Pharmaceuticals Announces Acquisition of ...

SAN DIEGO–(BUSINESS WIRE)–June 15, 2005–Novasite Pharmaceuticals Inc., a company focused on the discovery and development of allosteric modulators of G-protein coupled receptors (GPCRs), today announced that it has acquired PsyCheNomicS, Inc., a drug discovery company focused on diseases of the central nervous system (CNS). Financial terms of the transaction were not disclosed. “The PsyCheNomicS...

Magellan Biosciences buys TekCel

Chelmsford’s Magellan Biosciences has acquired TekCel, a Hopkinton-based maker of sample-management and assay-automation systems for biomedical research. Terms of the transaction were not disclosed. TekCel employs approximately 35 people, all of whom are expected to remain with the company, according to Magellan. According to Robert J. Rosenthal, president and chief executive officer of Magellan, the acquisition of...
Page 3 of 41234